Immunodiagnostic Systems Hldgs PLC Holding(s) in Company (8008S)
October 05 2017 - 4:39AM
UK Regulatory
TIDMIDH
RNS Number : 8008S
Immunodiagnostic Systems Hldgs PLC
05 October 2017
TR-1: Standard form for notification of major holdings
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant
issuer and to the FCA in Microsoft Word format if possible)(i)
-------------------------------------------------------------------------------------------------------
1a. Identity of the issuer Immunodiagnostic Systems
or the underlying issuer Holdings Plc
of existing shares to which GB00B01YZ052
voting rights are attached(ii)
:
-------------------------------------------------- ---------------------------------------------------
1b. Please indicate if the issuer is a non-UK issuer
(please mark with an "X" if appropriate)
-------------------------------------------------------------------------------------------------------
Non-UK issuer
---------------------------------------------------------------------------------------- -------------
2. Reason for the notification (please mark the appropriate
box or boxes with an "X")
-------------------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights x
---------------------------------------------------------------------------------------- -------------
An acquisition or disposal of financial instruments
---------------------------------------------------------------------------------------- -------------
An event changing the breakdown of voting rights
---------------------------------------------------------------------------------------- -------------
Other (please specify)(iii) :
---------------------------------------------------------------------------------------- -------------
3. Details of person subject to the notification obligation(iv)
Name AXXION S.A.
City and country of registered Luxembourg
office (if applicable)
4. Full name of shareholder(s) (if different from 3.)(v)
-------------------------------------------------------------------------------------------------------
Name
-------------------------------------------------- ---------------------------------------------------
City and country of registered
office (if applicable)
-------------------------------------------------- ---------------------------------------------------
5. Date on which the threshold 1st October 2017
was crossed or reached(vi)
:
-------------------------------------------------- ---------------------------------------------------
6. Date on which issuer notified 2nd October 2017
(DD/MM/YYYY):
-------------------------------------------------- ---------------------------------------------------
7. Total positions of person(s) subject to the notification
obligation
-------------------------------------------------------------------------------------------------------
% of voting % of voting Total of Total number
rights attached rights through both in % of voting
to shares financial (8.A + 8.B) rights of
(total of instruments issuer(vii)
8. A) (total of
8.B 1 + 8.B
2)
--------------------- ------------------------- ------------------ ---------------- ---------------
Resulting 9,50 29.411.297
situation
on the date
on which
threshold
was crossed
or reached
--------------------- ------------------------- ------------------ ---------------- ---------------
Position
of previous
notification
(if
applicable)
--------------------- ------------------------- ------------------ ---------------- ---------------
8. Notified details of the resulting situation on the
date on which the threshold was crossed or reached(viii)
--------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares
--------------------------------------------------------------------------------------------------------------
Class/type Number of voting rights(ix) % of voting rights
of
shares
ISIN code
(if possible)
--------------------
Direct Indirect Direct Indirect
(Art 9 of (Art 10 of (Art 9 of (Art 10 of
Directive Directive Directive Directive
2004/109/EC) 2004/109/EC) 2004/109/EC) 2004/109/EC)
(DTR5.1) (DTR5.2.1) (DTR5.1) (DTR5.2.1)
------------------- -------------------- ----------------- ------------------------------ ---------------
2.795.252 9,50
-------------------- -------------------- ----------------- ------------------------------ ---------------
SUBTOTAL
8. A 2.795.252 9,50
-------------------- --------------------------------------- -----------------------------------------------
B 1: Financial Instruments according to Art. 13(1)(a)
of Directive 2004/109/EC (DTR5.3.1.1 (a))
--------------------------------------------------------------------------------------------------------------
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date(x) Conversion rights that rights
Period(xi) may be acquired
if the instrument
is
exercised/converted.
-------------------- ------------------- ----------------- ------------------------------- ---------------
N/A
-------------------- ----------------- --------------------------------------------------- ---------------
SUBTOTAL 8.
B 1
----------------- --------------------------------------------------- ---------------
B 2: Financial Instruments with similar economic effect
according to Art. 13(1)(b) of Directive 2004/109/EC
(DTR5.3.1.1 (b))
--------------------------------------------------------------------------------------------------------------
Type of Expiration Exercise/ Physical Number % of voting
financial date(x) Conversion or cash of voting rights
instrument Period settlement(xii) rights
(xi)
------------------- -------------------- ---------------- ------------------- ----------- ---------------
SUBTOTAL
8.B.2
--------------------------------------- ----------- ---------------
9. Information in relation to the person subject to
the notification obligation (please mark the
applicable box with an "X")
Person subject to the notification obligation is x
not controlled by any natural person or legal entity
and does not control any other undertaking(s) holding
directly or indirectly an interest in the (underlying)
issuer(xiii)
Full chain of controlled undertakings through which
the voting rights and/or the
financial instruments are effectively held starting
with the ultimate controlling natural person or
legal entity(xiv) (please add additional rows as
necessary)
-------------------------------------------------------------- ---------------------
Name(xv) % of voting % of voting Total of both
rights if it rights through if it equals
equals or is financial instruments or is higher
higher than if it equals than the notifiable
the notifiable or is higher threshold
threshold than the notifiable
threshold
------------- ------------------ ------------------------- -----------------------
10. In case of proxy voting, please identify:
-------------------------------------------------------------------------------------
Name of the proxy holder N/A
--------------------------------- --------------------------------------------------
The number and % of voting N/A
rights held
--------------------------------- --------------------------------------------------
The date until which the N/A
voting rights will be held
--------------------------------- --------------------------------------------------
11. Additional information(xvi)
-------------------------------------------------------------------------------------
AXXION S.A.
Risk Management
Anna Angele
+352 / 76 94 94 563
-------------------------------------------------------------------------------------
Place of completion Luxemburg
-------------------- -----------
Date of completion 04.10.2017
-------------------- -----------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUVOWRBVARRRA
(END) Dow Jones Newswires
October 05, 2017 04:39 ET (08:39 GMT)
Immunodiagnostic Systems (LSE:IDH)
Historical Stock Chart
From Oct 2024 to Nov 2024
Immunodiagnostic Systems (LSE:IDH)
Historical Stock Chart
From Nov 2023 to Nov 2024
